Checkpoint Therapeutics Inc (NASDAQ: CKPT) kicked off on Monday, up 5.65% from the previous trading day, before settling in for the closing price of $3.01. Over the past 52 weeks, CKPT has traded in a range of $1.36-$3.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -47.67%. While this was happening, its average annual earnings per share was recorded 75.29%. With a float of $37.36 million, this company’s outstanding shares have now reached $45.02 million.
Let’s determine the extent of company efficiency that accounts for 23 employees. In terms of profitability, gross margin is -34223.08%, operating margin of -45501.28%, and the pretax margin is -54444.87%.
Checkpoint Therapeutics Inc (CKPT) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Checkpoint Therapeutics Inc is 17.01%, while institutional ownership is 13.21%. The most recent insider transaction that took place on Jun 26 ’24, was worth 50,450. In this transaction CEO, President and Director of this company sold 24,610 shares at a rate of $2.05, taking the stock ownership to the 1,977,170 shares. Before that another transaction happened on Jun 26 ’24, when Company’s Chief Financial Officer sold 13,038 for $2.06, making the entire transaction worth $26,858. This insider now owns 672,186 shares in total.
Checkpoint Therapeutics Inc (CKPT) Recent Fiscal highlights
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported -0.29 earnings per share (EPS), higher than consensus estimate (set at -0.76) by 0.47. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 75.29% per share during the next fiscal year.
Checkpoint Therapeutics Inc (NASDAQ: CKPT) Trading Performance Indicators
Take a look at Checkpoint Therapeutics Inc’s (CKPT) current performance indicators. Last quarter, stock had a quick ratio of 0.26. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1789.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.50, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.18 in one year’s time.
Technical Analysis of Checkpoint Therapeutics Inc (CKPT)
Looking closely at Checkpoint Therapeutics Inc (NASDAQ: CKPT), its last 5-days average volume was 0.97 million, which is a jump from its year-to-date volume of 0.46 million. As of the previous 9 days, the stock’s Stochastic %D was 88.87%. Additionally, its Average True Range was 0.18.
During the past 100 days, Checkpoint Therapeutics Inc’s (CKPT) raw stochastic average was set at 95.22%, which indicates a significant increase from 93.65% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 50.89% in the past 14 days, which was lower than the 59.79% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.34, while its 200-day Moving Average is $2.06. However, in the short run, Checkpoint Therapeutics Inc’s stock first resistance to watch stands at $3.29. Second resistance stands at $3.40. The third major resistance level sits at $3.56. If the price goes on to break the first support level at $3.03, it is likely to go to the next support level at $2.87. Now, if the price goes above the second support level, the third support stands at $2.76.
Checkpoint Therapeutics Inc (NASDAQ: CKPT) Key Stats
The company with the Market Capitalisation of 143.16 million has total of 35,686K Shares Outstanding. Its annual sales at the moment are 100 K in contrast with the sum of -51,850 K annual income. Company’s last quarter sales were recorded 40 K and last quarter income was -6,670 K.
